
  
    
      
        The_DT Problem_NNP of_IN Dyspnea_NNP and_CC Related_NNP Symptoms_NNP in_IN
        Hospice_NNP Patients_NNPS
        
          Research_NN Questions_NNS
          Severe_NNP dyspnea_NN ,_, whether_IN acute_JJ or_CC chronic_JJ ,_, affects_VBZ
          patients_NNS '_POS functional_JJ status_NN and_CC quality_NN of_IN life_NN as_RB well_RB
          as_IN other_JJ psychosocial_NN aspects_NNS of_IN the_DT patient_NN 's_POS life_NN ._. [_NN 6_CD
          ]_NN Patients_NNPS with_IN severe_JJ dyspnea_NN who_WP are_VBP in_IN hospice_NN care_NN
          most_RBS often_RB manifest_JJ the_DT associated_VBN symptoms_NNS and_CC problems_NNS
          of_IN anxiety_NN ,_, fatigue_NN ,_, and_CC sleeplessness_NNS which_WDT in_IN turn_NN
          affect_VB functional_JJ status_NN and_CC cognitive_JJ status_NN ,_, and_CC
          subsequently_RB decrease_VB quality_NN of_IN life_NN ._. [_NN 4_CD ]_NN Based_VBN on_IN
          previous_JJ studies_NNS ,_, [_NN 4_CD 6_CD 7_CD ]_NN a_DT specific_JJ study_NN aim_NN was_VBD to_TO
          explore_VB the_DT congruence_NN of_IN dyspnea_NN ratings_NNS by_IN caregivers_NNS
          with_IN patients_NNS '_POS ratings_NNS of_IN dyspnea_NN ._. Another_DT aim_NN was_VBD to_TO
          explore_VB the_DT relation_NN of_IN the_DT patient_NN 's_POS dyspnea_NN and_CC related_VBN
          variables_NNS to_TO the_DT patient_NN 's_POS quality_NN of_IN life_NN as_RB well_RB as_IN the_DT
          effect_NN on_IN the_DT caregiver_NN 's_POS quality_NN of_IN life_NN ._. The_DT study_NN
          addressed_VBD three_CD specific_JJ research_NN questions_NNS in_IN hospice_NN
          patients_NNS with_IN end-stage_JJ lung_NN cancer_NN and_CC their_PRP$
          caregivers_NNS ._.
          1_LS ._. Are_VBP there_EX significant_JJ differences_NNS in_IN the_DT intensity_NN
          ratings_NNS of_IN the_DT patients_NNS '_POS dyspnea_NN between_IN patients_NNS and_CC
          caregivers_NNS ?_.
          2_LS ._. To_TO what_WP extent_NN do_VBP these_DT patient-variables_JJ ,_, age_NN ,_,
          educational_JJ level_NN ,_, dyspnea_NN intensity_NN ,_, symptom_NN distress_NN ,_,
          and_CC functional_JJ status_NN ,_, explain_VB variance_NN in_IN the_DT patient_NN 's_POS
          perceived_VBN quality_NN of_IN life_NN ?_.
          3_LS ._. To_TO what_WP extent_NN do_VBP these_DT caregiver-variables_JJ ,_, age_NN ,_,
          educational_JJ level_NN ,_, dyspnea_NN intensity_NN ,_, symptom_NN distress_NN ,_,
          and_CC mastery_NN ,_, explain_VB variance_NN in_IN the_DT caregiver_NN 's_POS
          perceived_VBN quality_NN of_IN life_NN ._.
        
        
          Conceptual_NNP Framework_NNP
          The_DT conceptual_JJ framework_NN for_IN this_DT study_NN was_VBD adapted_VBN
          from_IN the_DT previous_JJ work_NN of_IN Moody_NNP ,_, McCormick_NNP ,_, and_CC Williams_NNP
          who_WP that_WDT found_VBD mastery_NN was_VBD associated_VBN with_IN improved_VBN
          symptom_NN management_NN which_WDT leads_VBZ to_TO improved_VBN functional_JJ
          status_NN and_CC perceived_VBN quality_NN of_IN life_NN ._. [_NN 4_CD ]_NN Another_DT
          underlying_VBG assumption_NN is_VBZ that_IN accurate_JJ assessment_NN of_IN
          symptoms_NNS leads_VBZ to_TO improved_VBN management_NN ,_, an_DT assumption_NN that_WDT
          has_VBZ yet_RB to_TO be_VB tested_VBN but_CC will_MD be_VB the_DT focus_NN of_IN a_DT future_JJ
          study_NN ._. In_IN the_DT present_JJ study_NN ,_, the_DT perceived_VBN mastery_NN level_NN
          of_IN the_DT patient_NN was_VBD not_RB measured_VBN but_CC it_PRP was_VBD assessed_VBN for_IN
          the_DT caregiver_NN ._.
          Nurses_NNP and_CC physicians_NNS often_RB fail_VBP to_TO assess_VB dyspnea_NN
          accurately_RB ,_, as_IN they_PRP tend_VBP to_TO assess_VB only_RB observable_JJ signs_NNS
          of_IN dyspnea_NN ._. Breathlessness_NNP ,_, the_DT subjective_JJ component_NN of_IN
          dyspnea_NN ,_, is_VBZ often_RB different_JJ from_IN what_WP is_VBZ directly_RB
          observable_JJ ._. [_NN 5_CD ]_NN Since_IN the_DT early_JJ 1980_CD s_VBZ ,_, there_EX have_VBP been_VBN
          a_DT number_NN of_IN tools_NNS available_JJ to_TO measure_VB dyspnea_NN in_IN acute_JJ
          and_CC chronic_JJ illness_NN ._. Studies_NNS ,_, which_WDT have_VBP measured_VBN dyspnea_NN
          appropriately_RB ,_, generally_RB use_NN a_DT quantitative_JJ method_NN of_IN
          self-assessment_JJ such_JJ as_IN the_DT visual_JJ analog_NN scale_NN or_CC a_DT
          graphic_JJ rating_NN scale_NN ._. The_DT graphic_JJ rating_NN scale_NN is_VBZ a_DT
          bipolar_NN scale_NN with_IN "_'' 0_CD "_'' for_IN "_'' No_DT dyspnea_NN "_'' and_CC "_'' 10_CD "_'' for_IN
          Worst_JJS Dyspnea_NNP Ever_RB ._. "_'' In_IN general_JJ ,_, a_DT graphic_JJ rating_NN scale_NN
          is_VBZ preferred_VBN for_IN older_JJR people_NNS ,_, hospice_NN patients_NNS ,_, and_CC
          those_DT who_WP are_VBP apt_JJ to_TO be_VB easily_RB fatigued_JJ ._. The_DT researchers_NNS '_POS
          previous_JJ experience_NN with_IN the_DT instrument_NN has_VBZ shown_VBN the_DT
          graphic_JJ rating_NN scale_NN to_TO be_VB the_DT best_JJS choice_NN for_IN caregivers_NNS
          in_IN terms_NNS of_IN ease_NN of_IN use_NN and_CC accuracy_NN ._. [_NN 4_CD 6_CD ]_NN
        
        
          Dyspnea_NNP and_CC Hospice_NNP Care_NNP
          In_IN hospice_NN patients_NNS ,_, it_PRP is_VBZ not_RB uncommon_JJ to_TO find_VB acute_JJ
          and_CC chronic_JJ dyspnea_NN because_IN most_JJS patients_NNS have_VBP one_CD of_IN
          these_DT primary_JJ diagnoses_NNS :_: end-stage_JJ lung_NN disease_NN (_( COPD_NNP or_CC
          interstitial_NN fibrosis_NNS )_) ,_, lung_NN cancer_NN ,_, or_CC end-stage_JJ heart_NN
          disease_NN ._. [_NN 7_CD ]_NN Aggressive_NNP treatment_NN of_IN distressing_JJ
          symptomatology_NN contributes_VBZ to_TO overall_JJ quality_NN of_IN life_NN and_CC
          restores_NNS to_TO the_DT patient_NN some_DT of_IN the_DT freedom_NN and_CC autonomy_NN
          usurped_JJ by_IN the_DT disease_NN process_NN ._.
          Dyspnea_NNP is_VBZ often_RB associated_VBN with_IN other_JJ common_JJ
          symptoms_NNS :_: fatigue_NN ,_, cough_NN ,_, anxiety_NN ,_, and_CC pain_NN ._. [_NN 5_CD ]_NN This_DT
          cluster_NN of_IN symptoms_NNS is_VBZ usually_RB studied_VBN together_RB ,_, and_CC
          caregivers_NNS are_VBP often_RB asked_VBN to_TO assess_VB all_DT of_IN them_PRP using_VBG
          various_JJ types_NNS of_IN analog_NN or_CC graphic_JJ rating_NN scales_NNS ._. In_IN
          planning_NN interventions_NNS for_IN dyspnea_NN ,_, it_PRP is_VBZ important_JJ to_TO
          assess_VB the_DT degree_NN of_IN distress_NN the_DT dyspnea_NN causes_NNS for_IN the_DT
          patient_NN and_CC in_IN turn_NN the_DT caregiver_NN ._. Moody_NNP and_CC other_JJ
          researchers_NNS have_VBP found_VBN ,_, that_IN the_DT onset_NN of_IN acute_JJ dyspnea_NN
          in_IN patients_NNS who_WP have_VBP not_RB experienced_VBN dyspnea_NN before_RB ,_, may_MD
          cause_VB severe_JJ anxiety_NN in_IN both_DT the_DT patient_NN and_CC the_DT
          caregiver_NN ._. [_NN 7_CD ]_NN In_IN order_NN to_TO improve_VB symptom_NN management_NN
          in_IN hospice_NN care_NN ,_, it_PRP is_VBZ important_JJ to_TO study_VB whether_IN
          caregivers_NNS are_VBP able_JJ to_TO use_VB the_DT assessment_NN tools_NNS and_CC
          achieve_VB ratings_NNS congruent_NN with_IN the_DT patient_NN 's_POS ratings_NNS ._.
        
        
          Caregivers_NNP in_IN Hospice_NNP Care_NNP
          Until_IN recently_RB ,_, most_JJS research_NN in_IN psychosocial_NN oncology_NN
          and_CC palliative_JJ care_NN focused_VBN exclusively_RB on_IN the_DT patient_NN ._.
          However_RB ,_, terminal_NN diseases_NNS are_VBP a_DT major_JJ stressor_NN for_IN both_DT
          the_DT patient_NN and_CC the_DT family_NN caregiver_NN ,_, causing_VBG a_DT new_JJ set_NN
          of_IN challenges_NNS for_IN both_DT ._. [_NN 8_CD ]_NN At_IN the_DT very_RB least_JJS ,_, the_DT
          routine_NN of_IN daily_JJ life_NN is_VBZ altered_VBN and_CC both_DT patients_NNS and_CC
          family_NN members_NNS must_MD struggle_VB to_TO adjust_VB and_CC respond_VB to_TO new_JJ
          demands_NNS ._. [_NN 9_CD ]_NN Recent_JJ research_NN suggests_VBZ that_IN family_NN
          caregivers_NNS experience_VBP depression_NN and_CC anxiety_NN ,_,
          psychosomatic_JJ symptoms_NNS ,_, restrictions_NNS of_IN roles_NNS and_CC
          activities_NNS ,_, strain_NN in_IN marital_JJ relationships_NNS ,_, and_CC
          diminished_VBD physical_JJ health_NN ._. [_NN 10_CD ]_NN Indeed_RB ,_, research_NN
          suggests_VBZ that_IN spouses_NNS experience_VBP as_IN much_JJ ,_, if_IN not_RB more_JJR ,_,
          distress_NN than_IN patients_NNS ._. [_NN 11_CD ]_NN This_DT emotional_JJ distress_NN
          may_MD affect_VB role_NN functioning_NN ,_, both_DT within_IN the_DT family_NN as_RB
          well_RB as_IN in_IN society_NN including_VBG the_DT ability_NN to_TO care_VB for_IN the_DT
          patient_NN ._. [_NN 12_CD ]_NN Caregiver_NNP distress_NN is_VBZ an_DT important_JJ
          concern_NN because_IN family_NN caregivers_NNS are_VBP assuming_VBG more_JJR
          responsibility_NN for_IN care_NN as_IN treatment_NN moves_NNS increasingly_RB
          to_TO the_DT outpatient_NN arena_NN ._. It_PRP is_VBZ increasingly_RB important_JJ to_TO
          evaluate_VB quality_NN of_IN life_NN (_( QOL_NNP )_) of_IN family_NN caregivers_NNS
          because_IN of_IN their_PRP$ increased_VBN responsibility_NN and_CC
          contribution_NN to_TO the_DT care_NN of_IN the_DT cancer_NN patient_NN ._. However_RB ,_,
          most_JJS studies_NNS to_TO date_NN have_VBP focused_VBN on_IN specific_JJ outcomes_NNS ,_,
          such_JJ as_IN needs_VBZ ,_, burden_NN ,_, and_CC emotional_JJ distress_NN rather_RB than_IN
          on_IN a_DT more_RBR comprehensive_JJ evaluation_NN of_IN QOL_NNP outcomes_NNS ._.
        
      
      
        Methods_NNP
        
          Setting_VBG and_CC Sample_NNP
          A_DT large_JJ hospice_NN provider_NN in_IN SW_NNP Florida_NNP was_VBD the_DT site_NN
          for_IN the_DT overall_JJ study_NN of_IN 300_CD patient_NN /_NN caregiver_NN dyads_NNS that_WDT
          had_VBD been_VBN accrued_VBN at_IN the_DT time_NN of_IN this_DT secondary_JJ analysis_NN ._.
          This_DT substudy_NN was_VBD focused_VBN on_IN the_DT 162_CD dyads_NNS (_( 54_CD percent_NN )_)
          from_IN the_DT sample_NN ,_, which_WDT were_VBD identified_VBN through_IN the_DT
          patient_NN 's_POS self-report_JJ of_IN dyspnea_NN at_IN the_DT time_NN of_IN
          admission_NN ._. To_TO be_VB eligible_JJ ,_, patients_NNS had_VBD to_TO be_VB adults_NNS (_( +_NN 18_CD
          years_NNS )_) with_IN a_DT diagnosis_NN of_IN cancer_NN and_CC an_DT identified_VBN
          family_NN caregiver_NN who_WP was_VBD a_DT spouse_NN or_CC adult_NN child_NN ,_, and_CC
          both_DT had_VBD to_TO consent_VB to_TO participate_VB ._. Both_DT had_VBD to_TO have_VB at_IN
          least_JJS a_DT sixth_JJ grade_NN education_NN ,_, be_VB able_JJ to_TO read_VB and_CC
          understand_VB English_NNP ,_, and_CC pass_VB cognitive_JJ screening_NN with_IN the_DT
          Short_NNP Portable_NNP Mini-mental_NNP Status_NNP Exam_NNP [_NN 13_CD ]_NN (_( Pfeiffer_NNP ,_,
          1974_CD )_) ._.
        
        
          Study_NNP Instruments_NNP
          
            Dyspnea_NNP Intensity_NNP
            For_IN hospice_NN patients_NNS with_IN severe_JJ dyspnea_NN and_CC
            fatigue_NN ,_, a_DT bipolar_NN 11_CD -_: point_NN Dyspnea_NNP Graphic_NNP Rating_NNP
            Intensity_NNP Scale_NNP (_( DGRIS_NNP )_) was_VBD used_VBN ._. [_NN 4_CD ]_NN This_DT global_JJ
            scale_NN ,_, which_WDT assesses_NNS only_RB the_DT perceived_VBN severity_NN of_IN
            the_DT dyspnea_NN ,_, was_VBD used_VBN due_JJ to_TO ease_NN of_IN administration_NN and_CC
            accuracy_NN ._. Reliability_NNP and_CC validity_NN of_IN the_DT one-item_JJ
            graphic_JJ rating_NN scales_NNS have_VBP been_VBN supported_VBN by_IN a_DT number_NN
            of_IN studies_NNS ._. Scores_NNS range_VBP from_IN 0_CD to_TO 10_CD ._. Test-retest_NNP
            reliability_NN has_VBZ ranged_VBN from_IN ._. 89_CD to_TO ._. 92_CD and_CC concurrent_JJ
            validity_NN with_IN other_JJ measures_NNS ._. 88_CD to_TO ._. 94_CD ._. [_NN 5_CD ]_NN Although_IN
            this_DT scale_NN was_VBD designed_VBN for_IN patient_NN self-report_JJ ,_, the_DT
            caregiver_NN also_RB was_VBD asked_VBN to_TO estimate_VB the_DT severity_NN of_IN
            the_DT patient_NN 's_POS dyspnea_NN ,_, using_VBG this_DT one-item_JJ scale_NN ._.
          
          
            Memorial_NNP Symptom_NNP Assessment_NNP Scale_NNP (_( MSAS_NNP )_)
            The_DT Memorial_NNP Symptom_NNP Assessment_NNP Scale_NNP [_NN 14_CD ]_NN was_VBD
            administered_VBN to_TO both_DT patients_NNS and_CC caregivers_NNS to_TO measure_VB
            both_DT the_DT frequency_NN and_CC distress_NN of_IN common_JJ symptoms_NNS
            experienced_VBN by_IN patients_NNS ._. For_IN patients_NNS ,_, it_PRP was_VBD used_VBN to_TO
            measure_VB distress_NN caused_VBN by_IN 24_CD symptoms_NNS commonly_RB seen_VBN in_IN
            persons_NNS with_IN advanced_JJ cancer_NN ,_, including_VBG shortness_NNS of_IN
            breath_NN ._. The_DT MSAS_NNP is_VBZ a_DT self-report_JJ scale_NN that_WDT provides_VBZ
            data_NNS about_IN the_DT occurrence_NN of_IN each_DT symptom_NN and_CC the_DT
            distress_NN associated_VBN with_IN these_DT symptoms_NNS ._. Distress_NNP is_VBZ
            measured_VBN on_IN a_DT 5_CD point_NN summated_JJ rating_NN scale_NN with_IN scores_NNS
            that_WDT may_MD range_VB from_IN 0_CD (_( no_DT distress_NN )_) to_TO 96_CD (_( very_RB much_RB
            distress_NN )_) ._. Validity_NNP was_VBD supported_VBN by_IN high_JJ correlations_NNS
            with_IN clinical_JJ status_NN and_CC quality_NN of_IN life_NN ._. Internal_NNP
            consistency_NN was_VBD assessed_VBN using_VBG Cronbach_NNP 's_POS alpha_NN and_CC
            found_VBD to_TO be_VB high_JJ ,_, ranging_VBG from_IN r_LS =_SYM ._. 83_CD to_TO ._. 88_CD ._. [_NN 15_CD 16_CD
            ]_NN
            The_DT MSAS_NNP scale_NN was_VBD administered_VBN to_TO all_DT caregivers_NNS ._.
            It_PRP was_VBD altered_VBN slightly_RB by_IN rewording_VBG items_NNS to_TO determine_VB
            the_DT degree_NN to_TO which_WDT each_DT symptom_NN experienced_VBN by_IN the_DT
            patient_NN caused_VBD distress_NN for_IN the_DT caregiver_NN ._. These_DT scores_NNS
            also_RB ranged_VBD from_IN 0_CD to_TO 96_CD ._. This_DT approach_NN has_VBZ been_VBN used_VBN
            previously_RB in_IN studies_NNS with_IN caregivers_NNS who_WP have_VBP
            dementia_NN ._. [_NN 15_CD ]_NN
          
          
            Hospice_NNP Quality_NNP of_IN Life_NNP Index_NNP
            The_DT Hospice_NNP Quality_NNP of_IN Life_NNP Index_NNP (_( HQLI_NNP )_) is_VBZ a_DT
            28_CD -_: item_NN self-report_JJ tool_NN that_WDT includes_VBZ three_CD aspects_NNS of_IN
            overall_JJ quality_NN of_IN life_NN :_: Psychophysiologic_NNP Well-being_NNP ;_:
            Functional_NNP Well-being_NNP ;_: and_CC Social_NNP and_CC Spiritual_NNP
            Well-being_NNP ._. [_NN 16_CD ]_NN Total_JJ scores_NNS may_MD range_VB from_IN a_DT low_NN of_IN
            zero_CD to_TO a_DT high_NN of_IN 280_CD ._. Evidence_NN of_IN validity_NN and_CC
            reliability_NN of_IN the_DT HQLI_NNP was_VBD generated_VBN by_IN a_DT recently_RB
            completed_VBN study_NN ._. [_NN 16_CD ]_NN Evidence_NN of_IN validity_NN was_VBD
            provided_VBN by_IN the_DT ability_NN of_IN the_DT HQLI_NNP to_TO differentiate_VB
            between_IN hospice_NN patients_NNS and_CC apparently_RB healthy_JJ
            controls_NNS using_VBG both_DT discriminate_JJ analysis_NN (_( p_NN =_SYM ._. 00_CD )_) and_CC
            comparison_NN of_IN means_NNS (_( p_NN =_SYM ._. 00_CD )_) ._. Previously_RB ,_, the_DT HQLI_NNP has_VBZ
            been_VBN validated_JJ for_IN use_NN with_IN hospice_NN patients_NNS with_IN
            cancer_NN ._. The_DT finding_VBG that_IN HQLI_NNP scores_NNS correlated_JJ at_IN the_DT
            expected_VBN level_NN (_( r_LS =_SYM ._. 26_CD ;_: p_NN =_SYM ._. 00_CD )_) with_IN functional_JJ
            status_NN scores_NNS provides_VBZ further_JJ evidence_NN of_IN validity_NN ._.
            Finally_RB ,_, factor_NN analysis_NN confirmed_VBD the_DT factor_NN structure_NN
            of_IN the_DT HQLI_NNP ._. Reliability_NNP of_IN the_DT HQLI_NNP was_VBD provided_VBN by_IN
            generation_NN of_IN coefficient_NN alphas_NNS for_IN both_DT total_JJ scale_NN
            scores_NNS and_CC subscale_NN scores_NNS ._. Subscale_NNP alphas_NNS all_DT were_VBD
            ._. 84_CD and_CC the_DT total_JJ scale_NN alpha_NN was_VBD high_JJ for_IN both_DT cancer_NN
            (_( r_LS =_SYM ._. 88_CD )_) and_CC AIDS_NNP (_( r_LS =_SYM ._. 93_CD )_) patients_NNS ._. For_IN this_DT paper_NN ,_,
            the_DT item_NN asking_VBG the_DT patient_NN how_WRB breathless_JJ he_PRP or_CC she_PRP
            feels_VBZ (_( 0_CD -_: 10_CD )_) was_VBD analyzed_VBN separately_RB ._.
            
            Mastery_NNP (_( Self-_NNP Efficacy_NNP )_) was_VBD
            assessed_VBN by_IN a_DT six-item_JJ summated_JJ rating_NN scale_NN with_IN a_DT
            five-point_JJ scale_NN ranging_VBG from_IN "_'' None_NN (_( 0_CD )_) "_'' to_TO "_'' A_DT Great_NNP
            Deal_NNP (_( 5_LS )_) "_'' ._. Scores_NNS may_MD range_VB from_IN 0_CD to_TO 30_CD ._. It_PRP was_VBD
            modified_VBN for_IN the_DT study_NN to_TO include_VB content-specific_JJ
            stems_VBZ based_VBN on_IN the_DT context_NN of_IN caregiving_VBG and_CC the_DT
            caregiver_NN 's_POS perceived_VBN ability_NN to_TO cope_VB with_IN caregiving_VBG
            tasks_NNS and_CC manage_VB day-to-day_JJ problems_NNS ._. The_DT mastery_NN scale_NN
            has_VBZ been_VBN used_VBN by_IN Moody_NNP ,_, et_CC al_NN ._. in_IN a_DT number_NN of_IN dyspnea_NN
            and_CC quality_NN of_IN life_NN studies_NNS ._. [_NN 4_CD 5_CD ]_NN Reliability_NNP of_IN the_DT
            scale_NN has_VBZ ranged_VBN from_IN ._. 88_CD to_TO ._. 94_CD ._. Content_NNP validity_NN and_CC
            concurrent_JJ validity_NN have_VBP ranged_VBN from_IN ._. 94_CD to_TO ._. 96_CD ._. [_NN 4_CD 5_CD
            ]_NN
          
          
            Palliative_NNP Performance_NNP Status_NNP (_( PPS_NNP )_) Scale_NNP
            The_DT purpose_NN of_IN the_DT Palliative_NNP Performance_NNP Scale_NNP
            (_( PPS_NNP )_) is_VBZ to_TO assess_VB the_DT physical_JJ condition_NN and_CC
            functional_JJ status_NN of_IN persons_NNS receiving_VBG palliative_JJ care_NN ._.
            [_NN 17_CD ]_NN Scores_NNS may_MD range_VB from_IN 0_CD (_( dead_JJ )_) to_TO 100_CD (_( normal_JJ
            functioning_NN )_) ._. It_PRP is_VBZ a_DT relatively_RB new_JJ tool_NN based_VBN on_IN the_DT
            Karnofsky_NNP Performance_NNP Scale_NNP and_CC is_VBZ purported_JJ to_TO provide_VB
            a_DT framework_NN for_IN measuring_VBG the_DT progressive_JJ decline_NN in_IN
            palliative_JJ care_NN patients_NNS ._. The_DT PPS_NNP measures_NNS three_CD broad_JJ
            areas_NNS of_IN function_NN :_: intake_NN ,_, level_NN of_IN consciousness_NN ,_, and_CC
            mobility_NN ._. The_DT PPS_NNP is_VBZ scored_VBN from_IN 0_CD -_: 100_CD %_NN at_IN 10_CD %_NN
            increments_NNS ._. The_DT PPS_NNP level_NN for_IN a_DT given_VBN patient_NN is_VBZ
            determined_VBN by_IN reading_VBG across_IN the_DT table_NN at_IN each_DT 10_CD %_NN
            decrement_NN to_TO find_VB the_DT overall_JJ best_JJS fit_VB ._. '_POS Stronger_JJR '_POS
            performance_NN factors_NNS are_VBP noted_VBN to_TO be_VB located_VBN on_IN the_DT left_VBN
            of_IN the_DT instrument_NN '_'' softer_JJR '_POS ones_NNS on_IN the_DT right_JJ ._. Judgment_NNP
            is_VBZ required_VBN if_IN one_CD of_IN the_DT five_CD factors_NNS observed_VBD in_IN a_DT
            particular_JJ patient_NN does_VBZ not_RB fit_VB with_IN the_DT others_NNS ._. The_DT
            usual_JJ approach_NN to_TO decide_VB PPS_NNP is_VBZ to_TO first_JJ determine_VB
            whether_IN the_DT disease_NN has_VBZ limited_VBD the_DT ability_NN to_TO work_VB or_CC
            ambulate_NN (_( left_VBD side_NN )_) ,_, and_CC then_RB work_VB one_CD 's_POS way_NN across_IN
            the_DT table_NN ._. Patients_NNS who_WP have_VBP a_DT lower_JJR PPS_NNP generally_RB are_VBP
            more_RBR functionally_RB impaired_VBN than_IN those_DT with_IN higher_JJR
            scores_NNS ._. Prognosis_NNP is_VBZ generally_RB related_VBN to_TO functional_JJ
            status_NN in_IN most_JJS palliative_JJ care_NN patients_NNS ._. Those_DT patients_NNS
            with_IN higher_JJR PPS_NNP scores_NNS may_MD have_VB longer_JJR length_NN of_IN stays_NNS ,_,
            although_IN all_DT patients_NNS may_MD not_RB be_VB comparable_JJ ._.
            Progression_NNP of_IN disease_NN can_MD generally_RB be_VB noted_VBN with_IN
            declining_VBG PPS_NNP levels_NNS in_IN a_DT given_VBN patient_NN ._. Interpretation_NNP
            of_IN the_DT instrument_NN may_MD have_VB implications_NNS about_IN patient_NN
            acuity_NN and_CC need_NN for_IN amount_NN of_IN services_NNS ._.
            The_DT initial_JJ validity_NN study_NN assessed_VBD 119_CD patients_NNS at_IN
            home_NN and_CC 213_CD patients_NNS admitted_VBN to_TO a_DT hospice_NN unit_NN ._.
            Validity_NNP of_IN this_DT instrument_NN was_VBD assessed_VBN comparing_VBG the_DT
            PPS_NNP score_NN with_IN length_NN of_IN survival_NN ._. The_DT average_JJ period_NN
            until_IN death_NN for_IN 129_CD patients_NNS who_WP died_VBD on_IN the_DT unit_NN was_VBD
            1_CD ._. 88_CD days_NNS at_IN 10_CD %_NN PPS_NNP on_IN admission_NN ,_, 2_CD ._. 62_CD days_NNS at_IN 20_CD %_NN ,_,
            6_CD ._. 7_CD days_NNS at_IN 30_CD %_NN ,_, 10_CD ._. 3_LS at_IN 40_CD %_NN ,_, 13_CD ._. 87_CD at_IN 50_CD %_NN ._. Only_RB two_CD
            patients_NNS at_IN 60_CD %_NN or_CC higher_JJR died_VBD in_IN the_DT unit_NN ._. As_IN part_NN of_IN
            an_DT earlier_JJR project_NN we_PRP assessed_VBD validity_NN and_CC reliability_NN
            of_IN the_DT PPS_NNP ._. The_DT predicted_VBD strong_JJ positive_JJ correlations_NNS
            between_IN PPS_NNP and_CC KFS_NNP (_( r_LS =_SYM ._. 88_CD ,_, p_NN =_SYM ._. 01_CD )_) support_NN
            construct_VB (_( convergent_NN )_) validity_NN ._. [_NN 17_CD ]_NN Although_IN no_DT
            reliability_NN data_NN were_VBD reported_VBN by_IN the_DT tool_NN developers_NNS ,_,
            the_DT researchers_NNS in_IN this_DT substudy_NN found_VBD that_IN inter-rater_JJ
            reliability_NN was_VBD very_RB strong_JJ (_( r_LS =_SYM ._. 95_CD ._. p_NN =_SYM ._. 01_CD ,_, df_NN
            162_CD )_) ._.
          
          
            Demographic_NNP Data_NNP
            Standard_NNP demographic_JJ data_NNS were_VBD collected_VBN on_IN dyads_NNS to_TO
            allow_VB description_NN of_IN the_DT sample_NN ._. Patient_NNP data_NNS included_VBD
            age_NN ,_, gender_NN ,_, education_NN level_NN ,_, marital_JJ status_NN ,_, religion_NN ,_,
            occupation_NN ,_, cancer_NN diagnosis_NN ,_, and_CC length_NN of_IN time_NN since_IN
            diagnosis_NN ._. Data_NNS on_IN caregivers_NNS were_VBD assessed_VBN by_IN
            self-report_JJ in_IN a_DT semistructured_JJ interview_NN :_: age_NN ,_,
            ethnicity_NN ,_, gender_NN ,_, education_NN ,_, marital_JJ status_NN ,_, and_CC
            religion_NN ._.
          
        
        
          Study_NNP Procedures_NNP
          This_DT study_NN was_VBD approved_VBN by_IN the_DT bioethics_NNS committees_NNS of_IN
          the_DT hospice_NN ._. Following_VBG approval_NN by_IN this_DT committee_NN ,_, the_DT
          proposal_NN was_VBD approved_VBN by_IN the_DT University_NNP of_IN South_NNP Florida_NNP
          Institutional_NNP Review_NNP Board_NNP for_IN the_DT Protection_NNP of_IN Human_NNP
          Subjects_NNP ._. Eligible_NNP dyads_NNS that_WDT were_VBD potential_JJ study_NN
          subjects_NNS were_VBD initially_RB identified_VBN by_IN hospice_NN admission_NN
          staff_NN and_CC referred_VBD to_TO the_DT Research_NNP Assistant_NNP (_( RA_NNP )_) ,_, a_DT
          trained_VBN nursing_NN data_NNS collector_NN ,_, at_IN the_DT beginning_NN of_IN each_DT
          day_NN ._. The_DT RA_NNP contacted_VBD the_DT caregiver_NN to_TO arrange_VB a_DT visit_NN by_IN
          both_DT the_DT nurse_NN and_CC a_DT Home_NNP Health_NNP Aide_NNP (_( HHA_NNP )_) ._. During_IN this_DT
          visit_NN ,_, the_DT study_NN was_VBD explained_VBN ,_, consent_NN of_IN both_DT patient_NN
          and_CC caregiver_NN obtained_VBD ,_, the_DT mental_JJ status_NN of_IN the_DT
          caregiver_NN assessed_VBD ,_, and_CC the_DT functional_JJ status_NN of_IN the_DT
          patient_NN evaluated_VBN ._. Patients_NNS and_CC caregivers_NNS who_WP met_VBD the_DT
          admission_NN criteria_NNS were_VBD asked_VBN to_TO complete_VB their_PRP$
          respective_JJ questionnaires_NNS independently_RB ,_, in_IN separate_JJ
          rooms_NNS when_WRB possible_JJ ._. The_DT HHA_NNP collected_VBD patient_NN data_NNS and_CC
          stayed_VBD with_IN the_DT patient_NN to_TO assist_VB as_IN needed_VBN ._. The_DT HHA_NNP
          reassured_VBD the_DT caregiver_NN that_IN the_DT patient_NN would_MD not_RB be_VB
          alone_RB while_IN the_DT RA_NNP was_VBD collecting_VBG data_NNS from_IN the_DT patient_NN ._.
          Therefore_RB ,_, the_DT caregiver_NN was_VBD better_RBR able_JJ to_TO concentrate_VB
          on_IN the_DT questionnaires_NNS knowing_VBG that_IN the_DT HHA_NNP was_VBD with_IN the_DT
          patient_NN ._.
        
        
          Data_NNP Analysis_NNP
          Data_NNS for_IN all_DT demographic_JJ variables_NNS and_CC study_NN variables_NNS
          were_VBD analyzed_VBN first_JJ using_VBG descriptive_JJ statistics_NNS with_IN
          SPSS_NNP version_NN 11_CD ._. 5_LS ._. [_NN 18_CD ]_NN Multiple_NNP correlation_NN and_CC paired_VBN
          t-tests_JJ were_VBD used_VBN to_TO analyze_VB significant_JJ differences_NNS in_IN
          ratings_NNS between_IN caregivers_NNS and_CC patients_NNS and_CC associations_NNS
          between_IN related_VBN symptoms_NNS and_CC conditions_NNS ._. Stepwise_NNP
          multiple_JJ regression_NN models_NNS were_VBD used_VBN to_TO address_VB research_NN
          questions_NNS two_CD and_CC three_CD ._.
        
      
      
        Results_NNS
        
          Profile_NNP of_IN Study_NNP Patients_NNPS and_CC Caregivers_NNP
          Usable_NNP data_NNS were_VBD collected_VBN on_IN 163_CD hospice_NN
          patients_NNS /_NN caregiver-dyads_JJ ._. A_DT profile_NN of_IN the_DT study_NN group_NN is_VBZ
          included_VBN in_IN Table_NNP 1_CD ._. The_DT mean_JJ age_NN of_IN the_DT hospice_NN patient_NN
          was_VBD 70_CD ._. 22_CD years_NNS and_CC 61_CD ._. 86_CD for_IN caregivers_NNS ._. About_IN 30_CD %_NN of_IN
          caregivers_NNS were_VBD adult_NN children_NNS and_CC the_DT majority_NN was_VBD
          spouses_NNS ._. The_DT dyad_NN majority_NN was_VBD white_JJ ,_, 85_CD %_NN ,_, 11_CD %_NN
          African-_NNP American_NNP ,_, 6_CD %_NN Hispanic_JJ ,_, and_CC 1_CD %_NN Asian_JJ ._. The_DT majority_NN
          of_IN patients_NNS were_VBD male_JJ ,_, 63_CD %_NN ,_, while_IN 74_CD %_NN of_IN caregivers_NNS were_VBD
          female_JJ ._. There_EX were_VBD no_DT mean_NN differences_NNS in_IN cognitive_JJ
          status_NN (_( SPMSQ_NNP )_) scores_NNS between_IN caregivers_NNS and_CC patients_NNS ._.
          The_DT education_NN level_NN of_IN patients_NNS was_VBD 12_CD ._. 1_LS years_NNS compared_VBN
          to_TO 12_CD ._. 8_CD for_IN caregivers_NNS ._. Eighty_NNP percent_NN of_IN
          dyad-participants_JJ had_VBD annual_JJ incomes_NNS of_IN less_JJR than_IN
          $_$ 50_CD ,_, 000_CD ._. Of_IN the_DT patient_NN sample_NN ,_, about_IN 40_CD percent_NN had_VBD lung_NN
          cancer_NN ,_, 14_CD percent_NN colon_NN cancer_NN ,_, 6_CD percent_NN breast_NN cancer_NN ,_,
          6_CD percent_NN prostate_NN ,_, and_CC 34_CD %_NN other_JJ types_NNS of_IN cancer_NN ._. Of_IN the_DT
          caregivers_NNS ,_, 75_CD %_NN reported_VBD one_CD or_CC more_RBR medical_JJ problems_NNS and_CC
          15_CD %_NN reported_VBD a_DT mental_JJ health_NN problem_NN ,_, mostly_RB
          depression_NN ._.
        
        
          Dyspnea_NNP Ratings_NNS and_CC Overall_RB Symptom_NNP Distress_NNP
          (_( MSAS_NNP )_)
          Mean_VB dyspnea_NN ratings_NNS as_IN reported_VBN by_IN the_DT patients_NNS was_VBD
          4_CD ._. 52_CD (_( SD_NNP 2_CD ._. 29_CD )_) and_CC by_IN the_DT caregivers_NNS was_VBD 4_CD ._. 39_CD (_( SD_NNP 2_CD ._. 93_CD )_) ._.
          To_TO address_VB research_NN question_NN one_CD ,_, a_DT paired_VBN ,_, two-tailed_JJ
          t-test_JJ was_VBD used_VBN to_TO assess_VB if_IN there_EX were_VBD significant_JJ
          differences_NNS between_IN caregivers-patient_JJ dyad_NN ratings_NNS of_IN
          the_DT patient_NN 's_POS dyspnea_NN intensity_NN ._. As_IN shown_VBN in_IN the_DT boxplot_NN
          in_IN Figure_NN 1_CD ,_, results_NNS indicated_VBD that_IN the_DT distribution_NN of_IN
          scores_NNS and_CC means_NNS were_VBD almost_RB identical_JJ (_( Mean_VB difference_NN =_SYM
          ._. -_: 13_CD ,_, t_NN =_SYM -_: ._. 53_CD ,_, df_NN 162_CD ,_, p_NN =_SYM ._. 59_CD )_) ._. Paired_NNP ,_, bivariate_NN
          correlation_NN was_VBD used_VBN to_TO determine_VB the_DT relationship_NN
          between_IN patient_NN and_CC caregiver_NN ratings_NNS of_IN dyspnea_NN ._. The_DT
          correlation_NN between_IN patient_NN and_CC caregiver_NN scores_NNS was_VBD weak_JJ
          but_CC significant_JJ (_( r_LS =_SYM ._. 33_CD ;_: p_NN =_SYM ._. 000_CD ,_, df_NN 1_CD ,_, 162_CD )_) ._.
          Patients_NNS '_POS mean_NN score_NN on_IN the_DT MSAS_NNP symptom_NN distress_NN
          scale_NN (_( Table_NNP 1_LS )_) ,_, which_WDT includes_VBZ 24_CD common_JJ symptoms_NNS
          experienced_VBN by_IN hospice_NN patients_NNS ,_, including_VBG dyspnea_NN were_VBD
          rated_VBN at_IN about_IN the_DT same_JJ level_NN ._. Mean_VB score_NN of_IN caregivers_NNS
          was_VBD 25_CD ._. 41_CD ,_, compared_VBN to_TO that_DT of_IN patients_NNS ,_, 25_CD ._. 60_CD ._.
        
        
          Factors_NNP Influencing_NNP Patients_NNPS '_POS Quality_NNP of_IN
          Life_NNP
          To_TO address_VB the_DT second_JJ research_NN question_NN ,_, a_DT stepwise_NN
          multiple_JJ regression_NN was_VBD used_VBN to_TO determine_VB if_IN these_DT
          patient-variables_JJ ,_, age_NN ,_, educational_JJ level_NN ,_, symptom_NN
          distress_NN (_( MSAS_NNP )_) ,_, dyspnea_NN intensity_NN ,_, and_CC functional_JJ status_NN
          (_( PPS_NNP )_) ,_, explained_VBD variance_NN in_IN the_DT dependent_JJ variable_NN ,_,
          patient_NN 's_POS perceived_VBN quality_NN of_IN life_NN (_( HRQL_NNP )_) ._. Variables_NNP
          were_VBD entered_VBN into_IN the_DT model_NN stepwise_NN with_IN quality_NN of_IN life_NN
          as_IN the_DT dependent_JJ variable_JJ (_( Table_NNP 2_LS )_) ._. All_DT variables_NNS were_VBD
          entered_VBN into_IN the_DT model_NN except_IN for_IN age_NN ,_, dyspnea_NN intensity_NN ,_,
          and_CC functional_JJ status_NN ._. Regression_NNP results_NNS indicated_VBD that_DT
          symptom_NN distress_NN and_CC education_NN were_VBD the_DT only_RB significant_JJ
          predictors_NNS of_IN the_DT patient_NN 's_POS quality_NN of_IN life_NN (_( R_NN 2_CD =_SYM ._. 35_CD ,_, p_NN
          =_SYM ._. 04_CD )_) ._.
        
        
          Factors_NNP Influencing_NNP Caregivers_NNP '_POS Quality_NNP of_IN
          Life_NNP
          The_DT third_JJ research_NN question_NN was_VBD examined_VBN using_VBG
          stepwise_NN multiple_JJ regression_NN to_TO determine_VB if_IN the_DT
          caregiver_NN 's_POS perceived_VBN levels_NNS of_IN mastery_NN ,_, symptom_NN
          distress_NN ,_, age_NN ,_, educational_JJ level_NN ,_, and_CC the_DT patient_NN 's_POS
          dyspnea_NN intensity_NN were_VBD significantly_RB related_VBN to_TO their_PRP$
          perceived_VBN quality_NN of_IN life_NN ._. All_DT variables_NNS were_VBD entered_VBN
          into_IN the_DT model_NN with_IN quality_NN of_IN life_NN as_IN the_DT dependent_JJ
          variable_NN ._. Results_NNS showed_VBD that_IN three_CD variables_NNS were_VBD
          significant_JJ predictors_NNS of_IN variance_NN in_IN the_DT caregivers_NNS '_POS
          quality_NN of_IN life_NN (_( R_NN 2_CD =_SYM ._. 40_CD ,_, p_NN =_SYM ._. 02_CD )_) :_: mastery_NN ,_, symptom_NN
          distress_NN ,_, age_NN ,_, and_CC education_NN (_( Table_NNP 2_LS )_) ._.
        
      
      
        Discussion_NNP
        Dyad_NNP ratings_NNS of_IN the_DT patients_NNS '_POS dyspnea_NN were_VBD almost_RB
        identical_JJ (_( paired_VBN mean_VB difference_NN was_VBD -_: 0_CD ._. 13_CD )_) ._. These_DT
        findings_NNS support_VBP other_JJ researchers_NNS such_JJ as_IN those_DT of_IN Sneeuw_NNP
        and_CC colleagues_NNS [_NN 21_CD ]_NN who_WP found_VBD that_IN ,_, with_IN few_JJ exceptions_NNS ,_,
        mean_VB scores_NNS of_IN the_DT proxy_NN raters_NNS were_VBD equivalent_JJ to_TO those_DT of_IN
        the_DT patient_NN ,_, varying_VBG between_IN 0_CD ._. 40_CD and_CC 0_CD ._. 60_CD ,_, indicating_VBG a_DT
        moderate_JJ level_NN of_IN agreement_NN at_IN the_DT individual_JJ level_NN ._.
        Disagreement_NNP was_VBD not_RB dependent_JJ on_IN the_DT type_NN of_IN proxy_NN rater_NN ,_,
        or_CC on_IN raters_NNS '_POS background_NN characteristics_NNS ,_, but_CC was_VBD
        influenced_VBN by_IN the_DT QOL_NNP dimension_NN under_IN consideration_NN and_CC the_DT
        clinical_JJ status_NN of_IN the_DT patient_NN ._. [_NN 21_CD ]_NN Although_IN our_PRP$
        findings_NNS also_RB confirm_VBP that_IN patient-caregiver_JJ dyspnea_NN
        ratings_NNS were_VBD not_RB significantly_RB different_JJ (_( mean_VB difference_NN
        -_: 0_CD ._. 19_CD )_) ,_, the_DT correlation_NN between_IN caregiver-patient_JJ ratings_NNS
        were_VBD significant_JJ but_CC relatively_RB not_RB that_IN strong_JJ (_( r_LS ._. 33_CD ,_, p_NN =_SYM
        ._. 000_CD ,_, df_NN 1_CD ,_, 162_CD )_) ._. Data_NNP were_VBD checked_VBN twice_RB for_IN accuracy_NN ,_,
        reanalyzed_JJ ,_, and_CC the_DT results_NNS were_VBD identical_JJ ._. Why_WRB the_DT
        correlation_NN is_VBZ not_RB stronger_JJR in_IN view_NN of_IN the_DT negligible_JJ mean_NN
        difference_NN in_IN paired-dyad_JJ ratings_NNS is_VBZ puzzling_JJ ._. The_DT results_NNS
        indicate_VBP that_IN both_DT significant_JJ others_NNS and_CC health_NN care_NN
        providers_NNS can_MD be_VB useful_JJ sources_NNS of_IN information_NN about_IN cancer_NN
        patients_NNS '_POS QOL_NNP ._. Measurement_NNP of_IN dyspnea_NN needs_VBZ to_TO be_VB done_VBN
        frequently_RB using_VBG standardized_JJ instruments_NNS ,_, such_JJ as_IN the_DT
        one-item_JJ ,_, graphic_JJ rating_NN scale_NN to_TO assess_VB dyspnea_NN and_CC
        effects_NNS of_IN treatments_NNS ._.
        Results_NNS of_IN the_DT regression_NN analysis_NN revealed_VBD that_IN the_DT
        patient_NN 's_POS perceived_VBN symptom_NN distress_NN and_CC educational_JJ level_NN
        are_VBP the_DT most_RBS important_JJ variables_NNS that_WDT explain_VBP variance_NN in_IN
        their_PRP$ quality_NN of_IN life_NN ._. This_DT finding_VBG is_VBZ similar_JJ to_TO a_DT
        previous_JJ study_NN by_IN Moody_NNP ,_, McCormick_NNP ,_, and_CC Williams_NNP ._. [_NN 4_CD ]_NN
        These_DT results_NNS confirm_VBP the_DT importance_NN of_IN assessing_VBG and_CC
        managing_VBG the_DT symptoms_NNS to_TO improve_VB or_CC maintain_VB quality_NN of_IN
        life_NN ._.
      
      
        Conclusions_NNP
        From_IN the_DT results_NNS ,_, it_PRP is_VBZ clear_JJ that_IN caregivers_NNS can_MD obtain_VB
        ratings_NNS of_IN dyspnea_NN that_WDT are_VBP congruent_NN with_IN the_DT patient_NN 's_POS
        perceived_VBN symptoms_NNS ._. This_DT is_VBZ especially_RB important_JJ in_IN hospice_NN
        care_NN as_IN patients_NNS may_MD become_VB so_RB debilitated_JJ that_IN they_PRP need_VBP
        to_TO rely_VB on_IN proxy_NN ratings_NNS from_IN their_PRP$ caregivers_NNS to_TO assess_VB
        and_CC attend_VB to_TO their_PRP$ symptom_NN management_NN Caregiver_NNP perceived_VBD
        quality_NN of_IN life_NN was_VBD related_VBN to_TO four_CD variables_NNS ,_, perceived_VBN
        mastery_NN ,_, symptom_NN distress_NN ,_, age_NN ,_, and_CC years_NNS of_IN education_NN ,_,
        with_IN mastery_NN being_VBG the_DT strongest_JJS predictor_NN ._. Overall_RB symptom_NN
        distress_NN and_CC education_NN were_VBD found_VBN to_TO be_VB the_DT best_JJS predictors_NNS
        of_IN the_DT patient_NN 's_POS quality_NN of_IN life_NN ._. In_IN the_DT current_JJ study_NN ,_,
        mastery_NN was_VBD tested_VBN only_RB in_IN the_DT caregivers_NNS ._. However_RB ,_, Moody_NNP
        and_CC colleagues_NNS found_VBD mastery_NN to_TO be_VB an_DT important_JJ predictor_NN
        of_IN the_DT patient_NN 's_POS quality_NN of_IN life_NN and_CC recommend_VB it_PRP be_VB
        assessed_VBN in_IN both_DT patient_NN and_CC caregiver_NN ._. [_NN 4_CD ]_NN
        Future_JJ research_NN in_IN the_DT form_NN of_IN clinical_JJ trials_NNS is_VBZ needed_VBN
        to_TO test_VB interventions_NNS to_TO manage_VB the_DT severe_JJ dyspnea_NN and_CC
        related_VBN symptoms_NNS that_WDT occur_VBP in_IN patients_NNS with_IN cancer_NN and_CC
        end-stage_JJ lung_NN disease_NN ._. Therapies_NNP for_IN dyspnea_NN in_IN the_DT
        hospice_NN setting_VBG have_VBP been_VBN subjected_VBN to_TO only_RB minimal_JJ
        scientific_JJ study_NN ,_, especially_RB for_IN end-stage_JJ chronic_JJ
        obstructive_JJ lung_NN disease_NN and_CC lung_NN cancer_NN ._. Evidence-based_NNP
        clinical_JJ guidelines_NNS such_JJ as_IN those_DT developed_VBN for_IN pain_NN
        management_NN are_VBP needed_VBN for_IN dyspnea_NN assessment_NN and_CC improved_VBN
        management_NN of_IN symptoms_NNS ._.
      
      
        Authors_NNP '_'' contributions_NNS
        LM_NNP carried_VBD out_RP the_DT data_NNS analysis_NN and_CC drafted_VBD the_DT
        manuscript_NN ._. SM_NNP is_VBZ PI_NNP and_CC LM_NNP is_VBZ co-investigator_JJ on_IN the_DT
        primary_JJ study_NN of_IN the_DT NIH-funded_NNP grant_NN from_IN the_DT National_NNP
        Cancer_NNP Institute_NNP ._. SM_NNP has_VBZ read_VBN ,_, approved_VBD ,_, and_CC contributed_VBD to_TO
        the_DT manuscript_NN ._.
      
    
  
